An update on the biology of sphingosine 1-phosphate receptors
Open accessThe DOI matches its Crossref record; 180 of the 184 references it cites were found in a registry or an index.
Abstract
Sphingosine 1-phosphate (S1P) is a membrane-derived lysophospholipid that acts primarily as an ex-tracellular signaling molecule. Signals initiated by S1P are transduced by five G protein-coupled receptors, named S1P1-5 Cellular and temporal expression of the S1P receptors (S1PRs) determine their specific roles in various organ systems, but they are particularly critical for regulation of the cardiovascular, immune, and nervous systems, with the most well-known contributions of S1PR signaling being modulation of vascular barrier function, vascular tone, and regulation of lymphocyte trafficking. However, our knowledge of S1PR biology is rapidly increasing as they become attractive therapeutic targets in several diseases, such as chronic inflammatory pathologies, autoimmunity, and cancer. Understanding how the S1PRs regulate interactions between biological systems will allow for greater efficacy in this novel therapeutic strategy as well as characterization of complex physiological networks. Because of the rapidly expanding body of research, this review will focus on the most recent advances in S1PRs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas DCs express S1PR1, S1PR3 and S1PR4, T cells display S1PR1 and S1PR4 (refs164–166)”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [166]
Citations
Cites
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Cited by
Items 501–548 of 548
PEPITEM, a regulator of leukocyte trafficking in ageing
Hopkin, S. J. (2023) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Bioactive lipids as neuroprotective targets in type 2 diabetes
Skoug, C. (2023) · Lund University Publications (Lund University)
Aranguren Esnal, I. (2024) · Communities in ADDI (University of the Basque Country)
Alegre, J. B. M., & Moreno, A. N. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Borghi, F., Jiang, Y., & Gnudi, L. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004239
“S1P signals through five G protein–coupled receptors (S1PR1–5) and is involved in diverse physiological processes, including vascular permeability , immune cell trafficking and regulation of vascular tone [29].”
Investigating the Role of 3-ketosphinganine Reductase (KDSR) in Acute Myeloid Leukemia
Ahn, J. S. Y. (2022) · TSpace (University of Toronto)
Regulation of vascular development and homeostasis by platelet-derived Sphingosine 1-Phosphate
Gazit, S. L. (2015) · theses.fr (ABES) · doi:10.70675/aa12b8adzf527z4e56zb399z48e7ad76c5d8
Castelain, L. (2016) · theses.fr (ABES) · doi:10.70675/de85fb68za461z4818zb122zcb0ccbec823e
Role of Phospholipase D in Vascular Calcification
Skafi, N. (2017) · HAL · doi:10.70675/4d0fac77z3d99z4f3dz91cez758184ef1346
Lalanne‐Mistrih, M. (2019) · theses.fr (ABES) · doi:10.70675/aa735006z75a2z4c63zaa8cz82d11d170a47
Sphingosine 1-phosphate signaling in platelet production
Niazi, H. (2020) · theses.fr (ABES) · doi:10.70675/806610d5z2070z4bd3z872dz5a2518384d19
Pérès, M. (2018) · theses.fr (ABES) · doi:10.70675/40e34110ze161z42a7zb179z142f56e19879 · Cited by 1
Guitton, J. (2023) · theses.fr (ABES) · doi:10.70675/68173ee7z6baez4c09zbbe6z97ecc31ca23a
Alomair, B. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093233
“S1P regulates vascular tone through S1PR2-and S1PR3-mediated effects on endothelial function and smooth muscle contraction [8].”
InfluentialSphingosine-1-Phosphate as an Immune-Metabolic Biomarker in Neurodegenerative Diseases
Kim, S. H., Jin, H. K., & Bae, J. (2026) · Journal of Clinical Neurology · doi:10.3988/jcn.2026.0158
“1,2,3 The sphingolipid metabolism is directly involved in this process, with S1P acting both as an intracellular second messenger and as an extracellular ligand for S1P receptors, and CNS cells—including microglia, astrocytes, and neurons—both regulate and respond to S1P signaling.”
The Role of Lipid Rafts in the Regulation of Piezo1 Channels in C2C12 Myoblasts
Bildyug, N. B., Vasileva, V. Y., Shenkman, B. S., & Mirzoev, T. M. (2026) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747826700078
“The receptors of S1P are represented by five G protein-coupled receptors, S1P 1–5 , which demonstrate overlapping or selective expression patterns in various cells and tissues [59].”
Bays, J., Teo, J. L., Rodriguez, F. S., Farrell, A. M., Stoddard, A. E., Koh, E., Hla, T., & Chen, C. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726610
Self-citationThe riddle of sphingolipid structure-function relationship in the nervous system
Muñoz-Gil, S., & Spassieva, S. D. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113258
“Neural progenitors express S1PR 1 and S1PR 2 , while differentiated neurons express S1PR 1 and S1PR 3 (98).”
Higher disease reactivation risk in women after fingolimod withdrawal
Massy, M., Marti, S., Kutllovci, A., Frahm, N., Fneish, F., Ellenberger, D., Hammer, H. N., Chan, A., Leichtle, A. B., Lühder, F., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02343-6
Khan, A., Vasquez, D. E. C., Si, Y., Vidar, W. S., Wu, K., Chiu, N., & Jia, Z. (2026) · Journal of Hazardous Materials · doi:10.64898/2026.07.09.736446
“M1 was prominently enriched for xenobiotic-detoxification pathways, including phase I cytochrome P450 metabolism and phase II glucuronidation, with hub genes such as Pgk1 and the atheroprotective lipid-signaling/endothelial-barrier mediator S1pr1 (Zanger and Schwab 2013, Blaho and Hla 2014).”
Sphingosine-1-phosphate (S1P) and its receptor S1PR2 in central nervous system diseases: a review
Hu, L., Wang, Z., Zhao, Z., Chen, Y., Ke, C., & Qiu, F. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00299-w
Sphingolipids and Atherosclerosis
Li, X., Li, Z., & Jiang, X. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01445-9
“Through these receptors, S1P regulates cell migration, adhesion, proliferation, and inflammatory path - ways [95, 96].”
Anyaegbunam, U. A., ten Cate, V., Bauer, K., Schmidlin, T., Distler, U., Tenzer, S., Araldi, E., Bîndilă, L., Wild, P., & Andrade-Navarro, M. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-70293-z
Ricigliano, V. A. G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1895118
“…(Figure 1A, BBB integrity and neuroin fl ammation), within the neurovascular unit, S1PR1 is the predominant receptor expressed by brain endothelial cells, where its activation stabilizes adherens and tight junctions, helps barrier function, and limits leukocyte transmigration into the CNS (16, 17).”
InfluentialVasconcelos, J. F., Barreto, B. C., Feitoza, M. S., Meira, C. S., Silva, D. N., Santos, G. C., das Neves, M. V. G., Azevedo, C. M., Daltro, P. S., Macambira, S. G., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-68280-5
Xu, Z., Deshang, X., Liu, K., Yijia, Y., Xingjie, H., Yang, F., Wenbin, N., Du, J., Rui, G., Li, Y., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03984-z
Raschmanová, J. Š., Ondrejkovičová, G., Pilátová, M. B., Kello, M., Janovec, L., Sudzina, A., Fábian, M., Kuchárová, V., Šesták, S., Mezencev, R., et al. (2026) · Carbohydrate Research · doi:10.1016/j.carres.2026.110121
Siegmund, B., Crosby, C. M., Ryan, R. D., Smith, J., Abreu-Martin, M. T., Séverine, V., Dotan, I., Rabinowitz, K. M., Komori, H. K., Goetsch, M., et al. (2026) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjag159
Nguyen, T. H., Hsu, S.-C., Chen, C.-L., Duong, C., Vu, T., Hoang, S., Nguyen, Q., Bui, A. T. T., Nguyen, C., & Tran, B. (2026) · Artery Research · doi:10.1007/s44200-026-00143-w
BindingDB Entry 50046175: GPCR crystal structures: Medicinal chemistry in the pocket.
BindingDB (2016) · UC San Diego · doi:10.7270/q2mc91s4
BindingDB (2017) · UC San Diego · doi:10.7270/q2gx4dd4
BindingDB Entry 50047393: Novel S1P1 receptor agonists - Part 5: From amino-to alkoxy-pyridines.
BindingDB (2017) · UC San Diego · doi:10.7270/q2m90bk2
BindingDB Entry 50049040: Kinase-independent phosphoramidate S1P
BindingDB (2019) · UC San Diego · doi:10.7270/q27p91n1
BindingDB (2024) · UC San Diego · doi:10.7270/q2zc874t
BindingDB (2022) · UC San Diego · doi:10.7270/q2v41021
BindingDB (2020) · UC San Diego · doi:10.7270/q2bg2rpc
Lipid-immune interplay in chronic inflammatory-based disorders
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8967-0
Methods for Testing Immunological Factors
Braddock, M. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_45-1
Metadata
- Authors
- Blaho, V. A., & Hla, T.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Hla, Timothy
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 55
- Issue
- 8
- Pages
- 1596-1608
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC4109755
- OpenAlex
- W2005467120
- Cited by
- 516
- References
- 184
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 35 · 2023: 49 · 2022: 31 · 2021: 59 · 2020: 48 · 2019: 46 · 2018: 52 · 2017: 49 · 2016: 48 · 2015: 29 · 2014: 10
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2239 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- National Heart, Lung, and Blood Institute (R01HL067330, R37HL067330, R01HL089934, P01HL070694)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, lysophospholipids, vascular barrier function, vascular tone, lymphocyte migration, chronic inflammation, autoimmunity, cancer, therapeutic target
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Lysophospholipids, Neoplasm Proteins, Neoplasms, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.